Summary

The Europe flow cytometry market is expected to reach USD 3.27 billion by 2032 from USD 1.49 billion in 2024, growing at a CAGR of 10.3% in the forecast period of 2025 to 2032.
Market Segmentation:
Europe Flow Cytometry Market, By Product (Reagents and Consumables, Flow Cytometry Instruments, Accessories, Services, and Software), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End user (Pharmaceuticals and Biotechnology Companies, Academic & Research Institutes, Hospitals, Clinical Testing Laboratories, CRO, Blood Bank, CMO & CDMO, Forensic Laboratories, and Others), Distribution Channel (Retail Sales and Direct Tenders), Country (Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, Austria, Ireland, Norway, Poland, and Rest of Europe) - Industry Trends & Forecast To 2032

Overview of Europe Flow Cytometry Market Dynamics:

Driver
• Rising Prevalence of Chronic Diseases
Restrain

• High Cost of Flow Cytometry Instruments

Opportunity

• Increase in Adoption of Flow Cytometry Techniques in Research and Academia

Market Players:

The key market players operating in the Europe flow cytometry market are listed below:

• BD
• Agilent Technologies, Inc.
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Sartorius AG
• Bennubio Inc.
• Enzo Biochem Inc.
• Apogee Flow Systems Ltd.
• Beckman Coulter, Inc.
• Coherent Corp.
• Cell Signaling Technology, Inc.
• Cytek Biosciences
• Biomérieux
• Cytonome/ST LLC

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 43
1.1 OBJECTIVES OF THE STUDY 43
1.2 MARKET DEFINITION 43
1.3 OVERVIEW OF THE EUROPE FLOW CYTOMETRY MARKET 43
1.4 CURRENCY AND PRICING 45
1.5 LIMITATIONS 45
1.6 MARKETS COVERED 45
2 MARKET SEGMENTATION 48
2.1 MARKETS COVERED 48
2.2 GEOGRAPHICAL SCOPE 49
2.3 YEARS CONSIDERED FOR THE STUDY 50
2.4 DBMR TRIPOD DATA VALIDATION MODEL 51
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 54
2.6 MULTIVARIATE MODELLING 55
2.7 DBMR MARKET POSITION GRID 56
2.8 VENDOR SHARE ANALYSIS 57
2.9 SECONDARY SOURCES 58
2.10 ASSUMPTIONS 58
3 EXECUTIVE SUMMARY 59
4 PREMIUM INSIGHTS 64
4.1 PESTAL ANALYSIS 65
4.2 PORTERS FIVE FORCES ANALYSIS 66
5 EUROPE FLOW CYTOMETRY MARKET: REGULATIONS 67
6 MARKET OVERVIEW 69
6.1 DRIVERS 71
6.1.1 RISING PREVALENCE OF CHRONIC DISEASES 71
6.1.2 INCREASING APPLICATION OF CYTOMETRY INSTRUMENTS 72
6.1.3 GROWING USE OF FLOW CYTOMETRY IN DRUG DISCOVERY 73
6.1.4 GROWING RESEARCH FUNDING 74
6.2 RESTRAINTS 75
6.2.1 HIGH COST OF FLOW CYTOMETRY INSTRUMENTS 75
6.2.2 LIMITATIONS OF FLOW CYTOMETRY 75
6.3 OPPORTUNITIES 77
6.3.1 INCREASE IN ADOPTION OF FLOW CYTOMETRY TECHNIQUES IN RESEARCH AND ACADEMIA 77
6.3.2 RISING DEVELOPMENT OF PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES 77
6.3.3 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 78
6.4 CHALLENGES 79
6.4.1 DIFFICULTY IN THE DEVELOPMENT AND VALIDATION OF FLOW CYTOMETRY ASSAYS 79
6.4.2 COMPLEXITIES RELATED TO REAGENT DEVELOPMENT 79
7 EUROPE FLOW CYTOMETRY MARKET, BY PRODUCT 81
7.1 OVERVIEW 82
7.2 REAGENTS AND CONSUMABLES 85
7.2.1 DYE 86
7.2.2 ANTIBODIES 86
7.2.3 BEADS 86
7.2.4 OTHERS 86
7.3 FLOW CYTOMETRY INSTRUMENTS 86
7.3.1 CELL ANALYZERS 88
7.3.1.1 CELL ANALYZERS, BY TYPE 88
7.3.1.1.1 IMAGING FLOW CYTOMETERS 88
7.3.1.1.2 NON-IMAGING FLOW CYTOMETERS 88
7.3.1.2 CELL ANALYZERS, BY RANGE 89
7.3.1.2.1 HIGH-RANGE CELL ANALYZERS 89
7.3.1.2.2 MID-RANGE CELL ANALYZERS 89
7.3.1.2.3 LOW-RANGE CELL ANALYZERS 89
7.3.1.3 CELL ANALYZERS, BY MODALITY 89
7.3.1.3.1 BENCHTOP 90
7.3.1.3.2 STANDALONE 90
7.3.2 CELL SORTERS 90
7.3.2.1 BENCHTOP 90
7.3.2.2 STANDALONE 90
7.3.3 CELL SORTERS 90
7.3.3.1 HIGH-RANGE CELL ANALYZERS 91
7.3.3.2 MID-RANGE CELL ANALYZERS 91
7.3.3.3 LOW-RANGE CELL ANALYZERS 91
7.4 ACCESSORIES 92
7.4.1 FILTERS 93
7.4.2 DETECTORS 93
7.4.3 OTHERS 93
7.5 SERVICES 94
7.6 SOFTWARE 94
8 EUROPE FLOW CYTOMETRY MARKET, BY TECHNOLOGY 95
8.1 OVERVIEW 96
8.2 CELL-BASED FLOW CYTOMETRY 99
8.2.1 FLOW CYTOMETRY INSTRUMENTS 100
8.2.2 REAGENTS & CONSUMABLES 100
8.2.3 ACCESSORIES 100
8.3 BEAD-BASED FLOW CYTOMETRY 100
8.3.1 FLOW CYTOMETRY INSTRUMENTS 100
8.3.2 REAGENTS & CONSUMABLES 100
8.3.3 ACCESSORIES 100
9 EUROPE FLOW CYTOMETRY MARKET, BY APPLICATION 101
9.1 OVERVIEW 102
9.2 RESEARCH APPLICATIONS 105
9.2.1 CELL CYCLE ANALYSIS 106
9.2.2 CELL SORTING/SCREENING 106
9.2.3 CELL TRANSFECTION/VIABILITY 106
9.2.4 PHARMACEUTICAL AND BIOTECHNOLOGY 106
9.2.4.1 DRUG DISCOVERY 106
9.2.4.2 STEM CELL RESEARCH 106
9.2.4.3 IN VITRO TOXICITY TESTING 106
9.2.5 IMMUNOLOGY 107
9.2.6 APOPTOSIS 107
9.2.7 CELL COUNTING 107
9.2.8 OTHERS 107
9.3 CLINICAL APPLICATIONS 107
9.3.1 HAEMATOLOGY 108
9.3.2 CANCER 108
9.3.3 IMMUNODEFICIENCY DISEASES 108
9.3.4 ORGAN TRANSPLANTATION 108
9.3.5 OTHER CLINICAL APPLICATION 108
9.4 INDUSTRIAL APPLICATIONS 108
10 EUROPE FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL 109
10.1 OVERVIEW 110
10.2 RETAIL SALES 113
10.2.1 OFFLINE 113
10.2.2 ONLINE 113
10.3 DIRECT TENDERS 114
11 EUROPE FLOW CYTOMETRY MARKET, BY END USER 115
11.1 OVERVIEW 116
11.2 PHARMACEUTICALS AND BIOTECHNOLOGY COMPANIES 119
11.3 ACADEMIC & RESEARCH INSTITUTES 120
11.4 HOSPITALS 120
11.5 CLINICAL TESTING LABORATORIES 121
11.6 CRO 121
11.7 BLOOD BANK 122
11.8 CMO & CDMO 122
11.9 FORENSIC LABORATORIES 123
11.10 OTHERS 123
12 EUROPE FLOW CYTOMETRY MARKET, BY REGION 124
12.1 EUROPE 126
12.1.1 GERMANY 136
12.1.2 FRANCE 145
12.1.3 U.K 153
12.1.4 ITALY 161
12.1.5 SPAIN 169
12.1.6 RUSSIA 177
12.1.7 NETHERLANDS 185
12.1.8 SWITZERLAND 193
12.1.9 TURKEY 201
12.1.10 BELGIUM 209
12.1.11 AUSTRIA 217
12.1.12 IRELAND 225
12.1.13 NORWAY 233
12.1.14 POLAND 241
12.1.15 REST OF EUROPE 248
13 EUROPE FLOW CYTOMETRY MARKET: COMPANY LANDSCAPE 249
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS 250
15 COMPANY PROFILES 251
15.1 BD 251
15.1.1 COMPANY SNAPSHOT 251
15.1.2 REVENUE ANALYSIS 251
15.1.3 COMPANY SHARE ANALYSIS 252
15.1.4 PRODUCT PORTFOLIO 252
15.1.5 RECENT DEVELOPMENT 255
15.2 AGILENT TECHNOLOGIES, INC. 256
15.2.1 COMPANY SNAPSHOT 256
15.2.2 REVENUE ANALYSIS 256
15.2.3 COMPANY SHARE ANALYSIS 257
15.2.4 PRODUCT PORTFOLIO 257
15.2.5 RECENT DEVELOPMENT 259
15.3 THERMO FISHER SCIENTIFIC INC 260
15.3.1 COMPANY SNAPSHOT 260
15.3.2 REVENUE ANALYSIS 261
15.3.3 COMPANY SHARE ANALYSIS 261
15.3.4 PRODUCT PORTFOLIO 261
15.3.5 RECENT DEVELOPMENT 264
15.4 BIO-RAD LABORATORIES, INC. 265
15.4.1 COMPANY SNAPSHOT 265
15.4.2 REVENUE ANALYSIS 265
15.4.3 COMPANY SHARE ANALYSIS 266
15.4.4 PRODUCT PORTFOLIO 266
15.4.5 RECENT DEVELOPMENT 267
15.5 SARTORIUS AG 268
15.5.1 COMPANY SNAPSHOT 268
15.5.2 REVENUE ANALYSIS 269
15.5.3 COMPANY SHARE ANALYSIS 269
15.5.4 PRODUCT PORTFOLIO 269
15.5.5 RECENT DEVELOPMENT 271
15.6 APOGEE FLOW SYSTEMS LTD. 272
15.6.1 COMPANY SNAPSHOT 272
15.6.2 PRODUCT PORTFOLIO 272
15.6.3 RECENT DEVELOPMENT 272
15.7 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORPORATION) 273
15.7.1 COMPANY SNAPSHOT 273
15.7.2 REVENUE ANALYSIS 273
15.7.3 PRODUCT PORTFOLIO 274
15.7.4 RECENT DEVELOPMENT 275
15.8 BIOMÉRIEUX 277
15.8.1 COMPANY SNAPSHOT 277
15.8.2 REVENUE ANALYSIS 277
15.8.3 PRODUCT PORTFOLIO 278
15.8.4 RECENT DEVELOPMENT 278
15.9 BIOLEGEND, INC. 279
15.9.1 COMPANY SNAPSHOT 279
15.9.2 PRODUCT PORTFOLIO 279
15.9.3 RECENT DEVELOPMENT 279
15.10 BENNUBIO INC 280
15.10.1 COMPANY SNAPSHOT 280
15.10.2 PRODUCT PORTFOLIO 280
15.10.3 RECENT DEVELOPMENT 280
15.11 COHERENT CORP. 281
15.11.1 COMPANY SNAPSHOT 281
15.11.2 REVENUE ANALYSIS 281
15.11.3 PRODUCT PORTFOLIO 282
15.11.4 RECENT DEVELOPMENT 282
15.12 CYTONOME/ST, LLC 283
15.12.1 COMPANY SNAPSHOT 283
15.12.2 PRODUCT PORTFOLIO 283
15.12.3 RECENT DEVELOPMENTS 284
15.13 CYTOBUOY 285
15.13.1 COMPANY SNAPSHOT 285
15.13.2 PRODUCT PORTFOLIO 285
15.13.3 RECENT DEVELOPMENT 286
15.14 CELL SIGNALING TECHNOLOGY, INC 287
15.14.1 COMPANY SNAPSHOT 287
15.14.2 PRODUCT PORTFOLIO 287
15.14.3 RECENT DEVELOPMENT 288
15.15 CYTEK BIOSCIENCES 289
15.15.1 COMPANY SNAPSHOT 289
15.15.2 PRODUCT PORTFOLIO 289
15.15.3 RECENT DEVELOPMENT 290
15.16 DIASORIN S.P.A. 291
15.16.1 COMPANY SNAPSHOT 291
15.16.2 REVENUE ANALYSIS 291
15.16.3 PRODUCT PORTFOLIO 292
15.16.4 RECENT DEVELOPMENT 292
15.17 ELABSCIENCE BIONOVATION INC. 293
15.17.1 COMPANY SNAPSHOT 293
15.17.2 PRODUCT PORTFOLIO 293
15.17.3 RECENT DEVELOPMENT 294
15.18 ENZO BIOCHEM, INC 295
15.18.1 COMPANY SNAPSHOT 295
15.18.2 REVENUE ANALYSIS 295
15.18.3 PRODUCT PORTFOLIO 296
15.18.4 RECENT DEVELOPMENT 297
15.19 MILTENYI BIOTEC AND/OR ITS AFFILIATES 298
15.19.1 COMPANY SNAPSHOT 298
15.19.2 PRODUCT PORTFOLIO 298
15.19.3 RECENT DEVELOPMENT 300
15.20 MERCK KGAA 301
15.20.1 COMPANY SNAPSHOT 301
15.20.2 REVENUE ANALYSIS 301
15.20.3 PRODUCT PORTFOLIO 302
15.20.4 RECENT DEVELOPMENT 303
15.21 NANOCELLECT BIOMEDICAL 304
15.21.1 COMPANY SNAPSHOT 304
15.21.2 PRODUCT PORTFOLIO 304
15.21.3 RECENT DEVELOPMENTS 305
15.22 NEOGENOMICS LABORATORIES 307
15.22.1 COMPANY SNAPSHOT 307
15.22.2 REVENUE ANALYSIS 308
15.22.3 PRODUCT PORTFOLIO 308
15.22.4 RECENT DEVELOPMENT 308
15.23 ON-CHIP BIOTECHNOLOGIES CO., LTD. CORPORATION 309
15.23.1 COMPANY SNAPSHOT 309
15.23.2 PRODUCT PORTFOLIO 309
15.23.3 RECENT DEVELOPMENTS 310
15.24 ORLFO TECHNOLOGIES 311
15.24.1 COMPANY SNAPSHOT 311
15.24.2 PRODUCT PORTFOLIO 311
15.24.3 RECENT DEVELOPMENT 311
15.25 STRATEDIGM, INC 312
15.25.1 COMPANY SNAPSHOT 312
15.25.2 PRODUCT PORTFOLIO 312
15.25.3 RECENT DEVELOPMENTS 313
15.26 SONY BIOTECHNOLOGY INC 314
15.26.1 COMPANY SNAPSHOT 314
15.26.2 PRODUCT PORTFOLIO 314
15.26.3 RECENT DEVELOPMENT 316
15.27 SYSMEX ASIA PACIFIC PTE LTD (PART OF SYSMEX CORPORATION) 317
15.27.1 COMPANY SNAPSHOT 317
15.27.2 REVENUE ANALYSIS 317
15.27.3 PRODUCT PORTFOLIO 318
15.27.4 RECENT DEVELOPMENT 319
15.28 TAKARA BIO INC. 320
15.28.1 COMPANY SNAPSHOT 320
15.28.2 PRODUCT PORTFOLIO 320
15.28.3 RECENT DEVELOPMENT 321
15.29 UNION BIOMETRICA, INC. 322
15.29.1 COMPANY SNAPSHOT 322
15.29.2 PRODUCT PORTFOLIO 322
15.29.3 RECENT DEVELOPMENTS 323
16 QUESTIONNAIRE 325
17 RELATED REPORTS 328